Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Operating Margin (2016 - 2025)

Ptc Therapeutics (PTCT) has 14 years of Operating Margin data on record, last reported at 480.94% in Q4 2025.

  • For Q4 2025, Operating Margin fell 40476.0% year-over-year to 480.94%; the TTM value through Dec 2025 reached 2.23%, up 7157.0%, while the annual FY2025 figure was 8.45%, 4596.0% up from the prior year.
  • Operating Margin reached 480.94% in Q4 2025 per PTCT's latest filing, down from 82.5% in the prior quarter.
  • Across five years, Operating Margin topped out at 82.5% in Q1 2025 and bottomed at 480.94% in Q4 2025.
  • Average Operating Margin over 5 years is 70.3%, with a median of 56.99% recorded in 2022.
  • Peak YoY movement for Operating Margin: soared 16449bps in 2021, then crashed -40476bps in 2025.
  • A 5-year view of Operating Margin shows it stood at 51.28% in 2021, then tumbled by -133bps to 119.67% in 2022, then surged by 102bps to 1.9% in 2023, then tumbled by -4119bps to 76.18% in 2024, then plummeted by -531bps to 480.94% in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Margin were 480.94% in Q4 2025, 82.5% in Q1 2025, and 76.18% in Q4 2024.